UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Synthorx Inc (THOR)

Synthorx Inc (THOR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
67.99 unch (unch) 01/22/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 67.99 unch (unch) -
Quote Overview for Wed, Jan 22nd, 2020
Day Low
67.99
Day High
68.01
Open 68.00
Previous Close 67.99 67.99
Volume 698,100 698,100
Avg Vol 508,775 508,775
Stochastic %K 4.23% 4.23%
Weighted Alpha +100.50 +100.50
5-Day Change -0.11 (-0.16%) -0.11 (-0.16%)
52-Week Range 11.05 - 71.90 11.05 - 71.90
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,198,661
  • Shares Outstanding, K 32,338
  • Annual Sales, $ 0 K
  • Annual Income, $ -56,610 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.44
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.12
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.39
  • Low Estimate -0.47
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +51.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.82 +0.25%
on 12/23/19
Period Open: 68.02
71.90 -5.44%
on 12/27/19
-0.03 (-0.04%)
since 12/20/19
3-Month
11.05 +515.29%
on 10/29/19
Period Open: 12.68
71.90 -5.44%
on 12/27/19
+55.31 (+436.20%)
since 10/22/19
52-Week
11.05 +515.29%
on 10/29/19
Period Open: 14.99
71.90 -5.44%
on 12/27/19
+53.00 (+353.57%)
since 01/22/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 68.02
1st Resistance Point 68.00
Last Price 67.99
1st Support Level 67.98
2nd Support Level 67.98
3rd Support Level N/A

See More

52-Week High 71.90
Last Price 67.99
Fibonacci 61.8% 48.66
Fibonacci 50% 41.48
Fibonacci 38.2% 34.29
52-Week Low 11.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades